Posted by AGORACOM-JC
at 7:12 PM on Friday, April 30th, 2021
When it comes to small-cap companies, tech-focused Datametrex AI is in rarefied air; they have not one but two successful independent divisions each capable of being a company maker: COVID-19 test kit distribution, and AI-driven social media monitoring and discovery.
Financial Highlights for year ending December 31, 2020:
Revenue of $12.3M vs. $3.4M for FY 2019
An increase of 264%
We sat down with CEO Marshall Gunter to discuss these highlights, the COVID-19 landscape, telemedicine, 2021 plans, and more.
Posted by AGORACOM-JC
at 6:21 PM on Thursday, April 29th, 2021
What do you get when you combine the leading provider of artificial intelligence driven real-time data insights for brick and mortar retailers, with the global leader in consumer data analytics operating in 100 markets and covering 90% of the world’s population?
Earlier today Loop Insights $MTRX $RACMF and NielsenIQ made this joint announcement that can be summarized by the following excerpt:
“NielsenIQ’s market leading fast-moving consumer goods coverage and Loop’s transformative artificial intelligence solutions present opportunities for collaboration and business development across channels. Retailers will benefit from an enhanced understanding of consumer behavior, thereby boosting personalization, targeting and activation initiatives through the joint power of NielsenIQ and Loop.”
More than just lip service, NielsenIQ is the leader in providing the most complete, unbiased view of consumer behavior, globally. Powered by a ground-breaking consumer data platform and fueled by rich analytic capabilities, NielsenIQ enables decision-making for the world’s leading consumer goods companies and retailers. In short, NielsenIQ measures every consumer transaction to deliver the knowledge that every business needs to drive growth.
If you thought that was powerful, the combination of Loop Insights means that knowledge will be delivered in real-time, something NielsenIQ VP Richard Lee says doesn’t exist in the market today.
How big is this alliance to $MTRX? This quote from CEO Rob Anson says it all:
“The scope, gravity and validation of this agreement with NielsenIQ represent an incredible milestone for Loop and its shareholders. NielsenIQ is the global leader when it comes to measurement and data analytics, as well as providing the most complete and trusted view of the market for leading CPG brands and retailers. In establishing this alliance, Loop is now on a path to achieve global enterprise scale, and has firmly put a stake in the ground as an emerging disruptive player in the world of retail data aggregation and analytics.”
Watch this powerful interview with NielsenIQ VP of Strategic Alliances, Richard Lee and Loop Insights CEO, Rob Anson to learn how they plan to transform the retail sector.
Posted by AGORACOM-JC
at 5:22 PM on Thursday, April 29th, 2021
Valeo Pharma is already a successful, revenue generating, small cap Canadian pharmaceutical company that acquires the Canadian rights to commercialized drugs in other parts of the world that don’t have Canada on their radar as a target market.
This “in-license” business model is ingenious because it means ZERO developmental or clinical risk, which is the downfall of most small cap pharma companies.
This model has resulted in the following success:
2020 net revenues of $7.5 million
2021 is expected to double to $15 million
Commercializing Novartis Asthma Therapies In Canada
Closed $6.6 Million Financing With Insiders Taking ~ 40%
If that was all Valeo had, most investors would be happy to sit back and watch the Company grow.
But then came Redesca. We are going to save you the science and tell you that Redesca belongs to a class of anticoagulant medications (blood thinners) called LMWH. The size of the Canadian LMWH market is over $200M per year and Valeo believes they can capture 15-20% of this market. If you’re doing back of napkin math, that equates to $30,000,000 – $40,000,000 per year in revenues.
But how does a new product capture that much market share? Glad you asked because we asked CEO Steve Saviuk the same question. Competition is tough in all markets and they don’t let someone take 15-20% market share without one hell of a fight. Saviuk agreed and gave the following 3 reasons:
1. Redesca has an 8-year international track record of safety and efficacy. It is already well known
2. Redesca is flat out cheaper, which is music to the ears of Provincial Health Ministries whose budgets have been stretched to the max this year no thanks to COVID-19.
Vaelo is so confident that it stated “This is great news for the Canadian healthcare system …. and is expected to help provide significant savings to provincial healthcare systems.”
More than just lip service, $VPH just announced that Redesca is now listed on the Ontario Public Drug Program, which means the government will cover its costs for all public use. Moreover, $VPH expects additional Provinces to follow.
If you love revenue generating, growing and blue sky potential small cap companies, then this Valeo interview is a must watch.
Posted by AGORACOM-JC
at 4:20 PM on Wednesday, April 28th, 2021
The paradigm shifting, parabolic growth of plant based foods and a plant based life is unstoppable, with the plant-based food market alone expected to reach $74.2 billion by 2027.
With a line up of plant based products and services that includes:
Plant Based Meal Delivery
Plant Based Snack Products
Plant Based Pet foods
Plant Based Restaurant Locator
Plant Based Recipes
Plant Based Essentials …. Like Chocolate (Essential? You Bet)
And …… Plant Based …. PLANTS (It’s A BIG Business!)
If you believe in the massive paradigm shift towards plant based foods and more, be sure to watch and share this great interview with PlantX CEO Julia Frank.
Posted by AGORACOM-JC
at 5:24 PM on Tuesday, April 27th, 2021
HealthSpace Data Systems’ (CSE: HS) (OTCQB: HDSLF) (Frankfurt: 38H) “empowering government efficiency” solution has empowered the firm to become an industry leading tech pioneer, providing both enterprise- and mobile internet-based applications to more than 500 state and local government organizations in North America. Including in:
Sonoma County, California
Jackson County, Missouri
Illinois
Wisconsin
Ontario, Canada
Today, the company announced the planned launch of a new platform, GovCall.
GovCall will be a leading teleconferencing platform focused exclusively on the government market. In order to accomplish this, the Company has entered into an exclusive partnership agreement with Iotum Inc., a leader in teleconferencing and group communications.
HealthSpace currently offers the only integrated product suite to incorporate inspection, administration and analytics across all platforms in North America.
A cloud-based and mobile platform helps revolutionize every aspect of government regulatory work
including licensing and inspections, accounting, even disease surveillance.
And underpinning its innovation is a robust business model:
Scalable with Strong Pipeline of Organic Growth
Fully funded and built to execute on all-time high sales pipeline of >$18m and growing
Sticky and Diversified Customer Base: Over 98% client retention year-over-year
Predictable Recurring Revenues, targeting $10m (Over 100% from YE2020) in Annual Recurring Revenue within 12 to 18 months
HealthSpace CEO Silas Garrison breaks down how GovCall will work and what it will mean for the company:
Posted by AGORACOM-JC
at 7:02 PM on Sunday, April 25th, 2021
Maitri Health Technologies is a global platform for healthcare supply security whose main focus provides a reliable source of certified PPE (personal protective equipment) and testing solutions through an onshore manufacturing model.
This model has led to the creation of innovative and industry leading products including 3D certified surgical masks and patent-pending face shields, all integrated with technology to help track, trace and enable safer workplaces and communities.
It all takes place against a backdrop of huge potential: the global personal protective equipment market size is expected to reach USD 123.38 billion by 2027, registering a CAGR of 9.6%.
After previously securing Health Canada approval for its domestically manufactured N95masks, the company has had a trio of big announcements over the course of the last month:
Maitri has been asked by the British Columbia Ministry of Jobs, Economic Recovery & Innovation to join a government-supported virtual trademission to the United Kingdom.
Andrew McCann, a digital innovator in cloud platforms and online user experiences, and co-founder of DeviantArt, has joined the company as Chief Technology Officer.
Maitri has appointed Bridget Ross, CEO of Israel-based MedTech company ChroniSense Medical, to its Advisory Board.
Andrew Morton, Maitri’s CEO, talks us through the developments:
Posted by AGORACOM-JC
at 4:42 PM on Friday, April 23rd, 2021
HPQ Silicon Resources $HPQ $HPQFF is a Quebec-based company that is developing a portfolio of high value-added silicon products sought after by battery and electric vehicle manufacturers.
If that sounds a lot like what other small companies are saying lately, $HPQ differentiates itself as a leader of the pack thanks to the following:
To discuss the importance and the implications of this milestone, this excerpt from the press release says it all:
“Once the final equipment modifications are completed, the goal of the program will be to produce qualified samples which will then be tested by a third-party, the Institut National de Recherche Scientifique (INRS), and subsequently to awaiting battery manufacturers and automobile manufacturers.”
Peter Pascali, President and CEO of PyroGenesis added a little more excitement when he stated
“It is even more exciting when one considers the impact this could have on addressing the challenges facing the EV battery space.”
Watch this great interview with $HPQ CEO Bernard Tourillon to get the full picture on next steps!
Posted by AGORACOM-JC
at 4:23 PM on Thursday, April 22nd, 2021
Cardiol Therapeutics $CRDL.ca $CRTPF is a groundbreaking, clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular disease (heart/blood vessels).
The company has received approval from the U.S. FDA to commence a Phase II/III, double-blind, placebo-controlled clinical trial investigating the efficacy and safety of its lead clinical product, CardiolRx™, in treating hospitalized COVID-19 patients with a prior history of, or risk factors for, cardiovascular disease (CVD).
CardiolRx™ is an ultra-pure, high concentration cannabidiol oral formulation that is pharmaceutically produced, manufactured under cGMP and THC free.
Cardiol is also planning a Phase II international trial of CardiolRx™ in acute myocarditis, a condition caused by inflammation in heart tissue, most common cause of sudden cardiac death in people under 35.
The company is also developing proprietary cannabidiol formulations for the treatment of chronic heart failure.
One such key development is its commercial product, Cortalex™, an extra-strength formulation (100 mg/mL concentration) of cannabidiol oil that is pharmaceutically produced to be free of THC. Cardiol believes Cortalex™ to be the purest form of cannabidiol oil available in Canada.
It is the first THC-free extra-strength formulation of cannabidiol oil available across Canada exclusively online at Medical Cannabis by Canada’s largest pharmacy retailer, Shoppers Drugs Mart.
In March 2020, Cardiol signed a supplier agreement to become a medical cannabidiol supplier to Shoppers Drug Mart. The retailer will supply Cardiol’s pharmaceutical cannabidiol products to Shoppers for sale in all provinces and territories in Canada through Shoppers’ online store, Medical Cannabis by Shoppers.
And there’s plenty more to write home about:
~ $27M from exercise of warrants + equity raise since June 2020
Uplisting to NASDAQ
Team expansion with Chief Medical Officer hire
David Elsley, Cardiol Therapeutics’ President & CEO, gives us the low-down. Check it out:
Posted by AGORACOM-JC
at 4:16 PM on Thursday, April 22nd, 2021
When 99.8% of investors read the headline to this press release, you couldn’t blame them for not understanding what it meant or how important it is to the future of POET Technologies
POET Technologies Announces Entry into Telecom Market with 100G LR4 (Long Reach) Optical Engines
But this is the great thing about AGORACOM Beyond The Press Release, which provides investors with a layman’s understanding of both the importance of the technology and its importance to the bottom line of $PTK …. and they are both very important.
A couple of things we can say that all investors would understand are the following:
The addressable market for this product (100G LR4 Transceiver) is ~ $USD 200 Million per year.
POET believes it can capture a very meaningful percentage of this market.
A 100G LR4 transceiver sells for about 2X to 3X the price of status quo products but delivers significantly better performance
POET’s product significantly reduces the cost of the optical engine allowing it to provide a savings to customers in the range of 25%
This 25% savings to customers often means the difference for viability
POET has design an optical engine that uses 10% to 15% less power to deliver data at the same speed and over the same distance as comparable modules
From a capital markets point or view, the Company’s NASDAQ uplisting plan is progressing on schedule.
POET believes it will provide large US investors with the further de-risking they have requested in 2020
You don’t have to be a computer scientist to understand the value of all these points. But you do have to watch this powerful interview in its entirety to understand the big picture.
Posted by AGORACOM-JC
at 11:04 AM on Thursday, April 22nd, 2021
Watch this powerful interview with David Gandini, Chairman & Chief Revenue Officer SOBR Safe (SOBR: OTCQB) as he demonstrates the practical application of the SOBRCheck device and it’s profound implications in the workplace.
With SOBRCheck, employers are able to ensure their employees and general public are safe from alcohol related “accidents” where costs are measured in lives.
“Nearly 50% of industrial injuries and fatalities are alcohol related. Commercial Fleets suffer from over 11,000 alcohol related accidents every year. That rate is climbing and technology has failed to keep pace with this epidemic”
If you have ever wondered why a technology can’t be created to prevent the senseless amount of deaths and injuries every year on our roads and workplace you are not alone. SOBRSafe is doing something great about it and everyone should take the time to absorb the positive change possible by watching this interview.
